MetAlert Subsidiary Level 2 Security Receives First Commercial Purchase Order for its Gun Tracker and Provides Update Post Acquisition
- MetAlert, through its subsidiary Level 2 Security, has received its first commercial order for the GunAlert® firearm recovery device from Range USA. The strategic timing of this expansion coincides with increased federal investment in programs to reduce gun crime and violence.
- None.
LOS ANGELES, CALIFORNIA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT) (“the Company”), a pioneer in GPS wearable technology and global provider in the field of human and asset tracking and recovery systems, announced through its
Patrick Bertagna, MetAlert CEO, reflected “We pioneered tracking and monitoring technology for humans with a primary goal of providing safety and peace of mind. Level 2's patented technology which specializes in monitoring unauthorized use and movement of firearms and other valuable mobile assets, is a natural synergistic extension to our product line, and ethos of providing technology that supports saving lives. We are excited about receiving our first commercial order from Range USA, the nation’s leading indoor range & gun store, offering customers the best variety of name brand firearms, gear, supplies and accessories.
MetAlert recently acquired Level 2 Security which provides motion detection and GPS technology to detect unauthorized movement or use of firearms and other valuable mobile assets, that require real time oversight and recovery assistance in case of unauthorized movement or theft. The strategic timing for expanding into this market coincides well with the Office of Justice Programs (“OJP”) recent announcement of investing unprecedented resources in programs designed to reduce gun crime and community violence. Last September
Tom Willingham, President and CEO of Range USA, expressed, “As part of our ongoing efforts to provide responsible gun use and safety education, we are excited to be one of the first to provide groundbreaking technology that can further enhance safety protocols and measures. Gun safety is paramount to our stated mission and we plan to roll out the GunAlert® product across all of our retail locations and make it available through our online sales, augmenting our current line of accessories.”
Patrick Bertagna concluded with, “We expect to play an important role in the national conversation surrounding gun safety and as part of that effort, we have begun providing police departments and police officers with evaluation units. We plan to work closely with Law Enforcement to help manage this channel and navigate access to the different federal grant programs currently available, along with working with the media to help bring attention to this game changing technology when it comes to gun safety.”
Explore our offerings at www.mygunalert.com and www.ifitmoves.com. For partnership or wholesale inquiries reach out to contactus@level2sec.com or info@metalert.com.
For consumer purchase - available on Amazon, Range USA, Level 2 online shop
Social Media:
FB: https://www.facebook.com/metalertinc
IG: https://www.instagram.com/metalert/?hl=en
Twitter: https://twitter.com/metalertinc
Linked In: https://www.linkedin.com/company/metalertinc/
YouTube: https://www.youtube.com/channel/UCUlYP1WQoLdKkDzwhGkx40Q
General information, investor relations, wholesale licensing, consumer purchase:
Tel: 213.489.3019 Email: info@metalert.com or ir@metalert.com website www.metalert.com
MetAlert
United Kingdom, London
Nelson Skip Riddle
Tel: +44 7785 364100
Email: nsriddle@metalert.com
About MetAlert, Inc.:
MetAlert (OTC: MLRT) and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services, and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer, dementia, and autism. This market represents approximately
Forward-Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document's content will not infringe the rights of third parties who are not owned or affiliated by MetAlert.
FAQ
What is the first commercial order received by MetAlert?
What is the significance of this expansion for MetAlert?
Where can consumers purchase the GunAlert® device?